Calgary Scientific Inc. Launches ResolutionMD 5.0 with Embedded Voice and Video Collaboration

CALGARY, ALBERTA, Feb. 18, 2015 — Calgary Scientific Inc., a company known for creating transformative technology for the medical industry and beyond, announced today the release of ResolutionMD® 5.0, which offers better access to health information, supports increased teamwork and enhances communication among practitioners and patients.

The new software version enables practitioners to instantly access expertise via live consultations using their web or mobile devices. Reports can now be created using voice dictation to complete patient records immediately and the need to physically transfer images on CD is drastically reduced with new image exchange capability.

There are many ways that healthcare enterprises can benefit from mobile access to expertise and images such as reimbursable telehealth programs. 

“The future of telemedicine will benefit greatly from technologies that simplify integration and help reduce costs such as ResolutionMD,” said Kyle Hall, Telehealth Coordinator at Nebraska Medicine. “Programs that include the use of mobile devices to communicate clinically relevant information among providers and their patients will ultimately improve patient care.”

The enhanced ResolutionMD 5.0 capability now includes:

  • Voice and video collaboration, connecting providers to other providers and their patients
  • Image sharing between facilities and providers, reducing the need to physically transfer images
  • Voice dictation for simplified report creation from mobile and web devices
  • Integration to EMR systems by Epic, Cerner and Allscripts, providing a complete view of patient records
  • XDS integration for greater accessibility and record sharing across or between healthcare enterprises
  • Precision measurements on mobile devices leveraging a unique and powerful lens tool for measurements on the go
  • Extended non-DICOM support for increased access to any file type

"The benefits realized by mobile access to information and expertise are ideally suited to the needs of healthcare. Applications such as telestroke and telehealth that integrate mobile image viewing capabilities have been proven to save valuable minutes in accessing images, thereby cutting the time it takes to begin diagnosis,” said Pierre Lemire, President and CTO of Calgary Scientific.  “The release of ResolutionMD 5.0, in combination with our global accreditations, offers leading technology to make virtual healthcare an industry standard."

Learn how organizations are integrating mobile image access to deliver better care – read the whitepaper.

About ResolutionMD®, Diagnostic Medical Imaging Software

ResolutionMD enables doctors to securely view patient images and reports from a wide variety of computers and mobile devices, collaborate with other practitioners and diagnose from any location. Whether you are a single facility or a large healthcare system with tens of thousands of users, ResolutionMD is the best choice for seamless image access across multiple departments. The FDA cleared, CFDA certified, ARTG certified, Health Canada licensed and CE marked mobile medical diagnosis software can be integrated into any EMR and easily plugs into existing distributed storage systems. ResolutionMD’s federated approach is an important differentiator from other solutions as highly sensitive data is never moved to a device and no additional data storage locations are created. ResolutionMD is published in 12 languages and is currently installed in leading healthcare institutions around the world via a network of more than 45 world class OEM healthcare partners.

For more information on ResolutionMD, go to http://www.calgaryscientific.com/resolutionmd

About Calgary Scientific Inc.

Calgary Scientific is the global leader in web and mobile diagnostic medical imaging solutions and collaboration enablement technologies. For more information on Calgary Scientific, go to www.calgaryscientific.com

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.